Profound Medical Corp sees a notable uptick in stock price, reflecting investor optimism.
Profound Medical Corp (PRN.TO) experienced a robust gain of 3.39% in the last trading session, closing at CA$9.75. This positive movement comes amidst a backdrop of significant operational achievements and financial growth, positioning the company favorably in the eyes of investors.
Investor takeaway: With strong revenue growth reported in Q1 2026 and strategic financial maneuvers, Profound Medical is capturing investor interest, suggesting a bullish outlook for the near term.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$377.18M
52W high
$12.40
52W low
$5.23
1W change
-0.57%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 141.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+141.1% Upside
Current Price
C$10.38
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
41.4%
Annualized
90-Day Vol
51.6%
Annualized
Trend (90d)
+20.3%
Annualized drift
90d Mean
C$11.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.63 | C$9.22 – C$12.27 |
| 60 trading days | C$10.89 | C$8.90 – C$13.33 |
| 90 trading days | C$11.16 | C$8.72 – C$14.29 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bull case
Profound Medical's recent revenue growth of 104% in Q1 2026 and the addition of Humana coverage for the TULSA Procedure™ indicate strong operational performance and market acceptance. These developments could lead to further stock appreciation.
Bear case
Despite the positive momentum, investors should remain cautious. The company still operates at a loss, with a profit margin of -2.07%, which could affect its long-term sustainability.
Strong Financial Performance
Advertisement
Profound Medical recently reported a staggering 104% increase in revenue for Q1 2026, showcasing its ability to grow despite market challenges. This financial success is a key driver behind the stock's upward movement, as investors respond positively to the company's operational efficiency and market strategies.
Strategic Developments Enhance Market Position
The addition of Humana coverage for the TULSA Procedure™ is a significant milestone for Profound Medical, enhancing its market presence and accessibility. This strategic move not only expands the company's reach but also reinforces investor confidence in its growth trajectory.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
